Expert Interview
Examining the potential of Kodiak's KSI-501 in patients with Diabetic Macular Edema
Ticker(s): KODInstitution: Rush University & Illinois Retina Associates
- Assistant Professor of Ophthalmology at Rush University Medical Center & co-investigator on several clinical trials.
- Manages 20 patints a week with wAMD.
- Research interests include assessing the color performance of the NGENUITY 3D visualization system and meta-analyses of cytokines in various retinal diseases; clinical focus on the medical and surgical treatment of diseases affecting the retina, vitreous and macula.
Roughly how many patients with Diabetic Macular Edema do you currently manage?
Added By: dami_adminRoughly how many patients with diabetic retinopathy do you currently manage?
Added By: dami_adminRoughly how many patients with wet age-related macular degeneration do you currently manage?
Added By: dami_adminRoughly how many patients with retinal vein occlusion do you currently manage?
Added By: dami_adminOn a scale from 1-10 (10 being extremely excited) where would you rate your level of excitement for tarcocimab tedromer?
Added By: dami_adminAre You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
